In tumours themselves, consistent changes in the expression of clock genes (e.g. Per1–3) have been demonstrated, as well as changes in the methylation state of their regulatory regions in various tissues including breast, liver and endometrial cancers [76–78]. Here, CLOCK is linked to neoplasm.